A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate
- 1 November 1992
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 209 (3) , 985-992
- https://doi.org/10.1111/j.1432-1033.1992.tb17372.x
Abstract
Recombinant plasminogen-activator-inhibitor type 1 (PAI-1) purified in an active form from Escherichia coli and eucaryotic cells was found to contain a mixture of three functionally distinct forms: an active form that forms complexes with plasminogen activators (PAs), an inactive (latent) form that remains intact after incubation with PAs, and a substrate-like form which is easily cleaved by PAs. Since active PAI-1 purified from bacteria (rpPAI-1) contains only trace amounts of the inactive latent and the substrate-like forms, this material was used to study the effect of sodium dodecyl sulphate (SDS) on the structure and function of active PAI-1. After treatment with 0.01% SDS, active rpPAI-1 was converted to an inactive form that did not form complexes with PAs, but exhibited characteristics similar to those of latent PAI-1. After treatment with 0.1% SDS, PAI-1 lost its inhibitory activity and was cleaved as a substrate in the reactive center. Circular dichroism spectral analysis reveals that SDS changed the conformation of PAI-1 dramatically, mainly by increasing its alpha-helical content.Keywords
This publication has 34 references indexed in Scilit:
- Structural basis of latency in plasminogen activator inhibitor-1Nature, 1992
- A spectroscopic study of the conformations of active and latent forms of recombinant plasminogen activator inhibitor-1Biochemical and Biophysical Research Communications, 1991
- Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein CBiochemistry, 1989
- Purification and characterization of natural and recombinant human plasminogen activator inhibitor‐1 (PAI‐1)European Journal of Biochemistry, 1988
- Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencingFEBS Letters, 1986
- Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular massFEBS Letters, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroismJournal of Molecular Biology, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Computed circular dichroism spectra for the evaluation of protein conformationBiochemistry, 1969